Total Return chart Myriad Genetics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-26 EDT			5-day change	1st Jan Change
5.880 ^USD	+8.29%		+29.52%	-4.39%

06-23	Myriad Genetics, Inc. Announces Resignation of Daniel M. Skovronsky from Director, Effective June 17, 2026	CI
06-23	Myriad Genetics Expands Availability of Precise Mrd for Colorectal, Renal and Breast Cancers	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.